CSIA
ABBV icon

Conrad Siegel Investment Advisors’s AbbVie ABBV Stock Holding History

Conrad Siegel Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$8K – 27
2022
Q1 		$8K Buy
+50
New +$7.26K 0.01% 43

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Conrad Siegel Investment Advisors's ABBV Position: Q2 2022 in Review

Conrad Siegel Investment Advisors sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 50 shares — an estimated $8K sold.

Conrad Siegel Investment Advisors first reported a position in ABBV in Q1 2022 and held it in 1 quarter. The position peaked at $8K in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Conrad Siegel Investment Advisors reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
  • Conrad Siegel Investment Advisors sold 50 AbbVie shares in Q2 2022, an estimated $8K.
  • Conrad Siegel Investment Advisors first reported a position in AbbVie in Q1 2022 and held it in 1 quarter.
  • Conrad Siegel Investment Advisors's AbbVie position peaked at $8K in Q1 2022.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Conrad Siegel Investment Advisors's 13F filing for Q2 2022, filed 22 Jul 2022.